Louis R. Verdetto - 02 Dec 2025 Form 4 Insider Report for Strata Critical Medical, Inc. (SRTA)

Role
CEO Keystone Perfusion Service
Signature
/s/ Melissa M. Tomkiel, Attorney-in-fact for Louis R. Verdetto
Issuer symbol
SRTA
Transactions as of
02 Dec 2025
Transactions value $
$0
Form type
4
Filing time
04 Dec 2025, 16:21:39 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Verdetto Louis R. CEO Keystone Perfusion Service C/O STRATA CRITICAL MEDICAL, INC., 31 HUDSON YARDS, 14TH FLOOR, NEW YORK /s/ Melissa M. Tomkiel, Attorney-in-fact for Louis R. Verdetto 04 Dec 2025 0002095962

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRTA Class A common stock, $0.0001 par value per share Award $0 +63.9K +5.97% $0.00 1.13M 02 Dec 2025 Direct F1
holding SRTA Class A common stock, $0.0001 par value per share 132K 02 Dec 2025 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 25% of the RSUs (rounded down to the nearest whole number) to become vested on September 8, 2026 and then 6.25% (rounded down to the nearest whole number) will vest every 3 months thereafter, with any remaining unvested RSUs to vest on September 8, 2029, subject to the Reporting Person's continued service to the Issuer.
F2 The reported securities are held by the LOUIS VERDETTO IRREVOCABLE TRUST DATED AUGUST 20 2025 for which the Reporting Person serves as the trustee.